- Research works
- 78 ▼ 29% vs 2013–17
- Citations
- 1.4k 17.5 per fractional work
- Top-10% rate
- 18.9% record average 16.5%
- Open access
- 43% world 28%
Not ranked overall: Pfizer (Netherlands) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.8×. Every wedge is a field page.
- Immunology and Microbiology 4.8×
- Economics, Econometrics and Finance 4.6×
- Mathematics 4.4×
- Medicine 2.8×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Agricultural and Biological Sciences 1.4×
- Health Professions 1.4×
- Biochemistry, Genetics and Molecular Biology 1.1×
- Nursing 1.1×
- Environmental Science 0.6×
- Neuroscience 0.5×
- Psychology 0.3×
- Physics and Astronomy 0.3×
- Materials Science 0.1×
- Social Sciences 0.1×
- Engineering 0.1×
Who are the top researchers at Pfizer (Netherlands)?
Ranked on the composite score, René van Kralingen and Pieter Mostert lead among researchers whose main affiliation is Pfizer (Netherlands).
- 1 René van Kralingen Netherlands · #1,073,301 worldwide 0 citations · 15 works
- 2 Pieter Mostert Netherlands · #1,212,566 worldwide 0 citations · 15 works
Which keywords describe research at Pfizer (Netherlands)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Clinical Practice Guidelines, Antimicrobial Resistance, Respiratory Infections, Health Promotion, Professionalism, Research Methods and Social Work.
- phosphate
- Rheumatoid Arthritis
- FGF23
- Autoantibodies
- Health Utility Measures
- Catheter Ablation
- Chronic Kidney Disease
- Cardiac Amyloidosis
- Guidelines
- Cardiovascular Magnetic Resonance
- Globalization
- Inflammation
- Quality of Life
- Cardiovascular Risk
- Treatment
- Community-Acquired Pneumonia
- Research Methods
- Health Promotion
- Antimicrobial Resistance
- Clinical Practice Guidelines
- Epidemiology
- Education
- Respiratory Infections
- Professionalism
- Social Work
- Pneumococcal Conjugate Vaccine
- Vaccine Development
- Diagnosis
- Human Metapneumovirus
- Respiratory Syncytial Virus
- Economic Evaluation
- Echocardiography
- Prognosis
- Transthyretin
- Vaccine
- Cost-effectiveness Analysis
- Pharmaceutical Industry
- Biological Therapy
- Parathyroid Hormone
- Viral Pathogenesis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology13▲ 4.2×32 topics
- Clinical Practice Guidelines5▲ 11×7 topics
- Education5▲ 4.7×4 topics
- Antimicrobial Resistance4▲ 22×4 topics
- Respiratory Infections4▲ 62×2 topics
- Health Promotion4▲ 19×2 topics
- Professionalism4▲ 42×2 topics
- Research Methods4▲ 43×1 topic
- Social Work4▲ 68×1 topic
- Community-Acquired Pneumonia4▲ 123×1 topic
- Pneumococcal Conjugate Vaccine4▲ 123×1 topic
- Treatment4▲ 3.8×11 topics
- Vaccine Development4▲ 15×4 topics
- Cardiovascular Risk3▲ 12×5 topics
- Diagnosis3▲ 4.0×7 topics
- Quality of Life3▲ 3.0×8 topics
- Human Metapneumovirus3▲ 87×1 topic
- Inflammation3▲ 1.69×12 topics
- Respiratory Syncytial Virus3▲ 87×1 topic
- Globalization3▲ 2.0×4 topics
- Economic Evaluation3▲ 27×2 topics
- Cardiovascular Magnetic Resonance2▲ 53×2 topics
- Echocardiography2▲ 12×5 topics
- Guidelines2▲ 6.1×5 topics
- Prognosis2▲ 8.6×2 topics
- Cardiac Amyloidosis2▲ 136×1 topic
- Transthyretin2▲ 136×1 topic
- Chronic Kidney Disease2▲ 9.4×4 topics
- Vaccine2▲ 5.8×6 topics
- Catheter Ablation2▲ 16×2 topics
- Cost-effectiveness Analysis2▲ 27×1 topic
- Health Utility Measures2▲ 27×1 topic
- Pharmaceutical Industry2▲ 50×2 topics
- Autoantibodies2▲ 8.1×2 topics
- Biological Therapy1▲ 33×1 topic
- FGF231▲ 48×1 topic
- Parathyroid Hormone1▲ 18×2 topics
- Rheumatoid Arthritis1▲ 18×1 topic
- Viral Pathogenesis1▲ 23×2 topics
- phosphate1▲ 48×1 topic
Which research topics does Pfizer (Netherlands) publish most on?
By volume in 2022–2025: Respiratory viral infections research, Pneumonia and Respiratory Infections, Diverse Scientific and Economic Studies and Animal Disease Management and Epidemiology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 2 works
- 2 Pneumonia and Respiratory Infections Epidemiology 2 works
- 3 Diverse Scientific and Economic Studies Economics and Econometrics 1 works
- 4 Animal Disease Management and Epidemiology Agronomy and Crop Science 1 works
- 5 Amyloidosis: Diagnosis, Treatment, Outcomes Molecular Biology 1 works
- 6 Advanced Causal Inference Techniques Statistics and Probability 1 works
- 7 Energy and Environment Impacts Pollution 0 works
- 8 Pericarditis and Cardiac Tamponade Cardiology and Cardiovascular Medicine 0 works
- 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 0 works
- 10 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Pfizer (Netherlands)'s research output changed?
Output in 2018–2022 was 29% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Capelle aan den IJssel
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.